NCT04119024 2026-03-17Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid TumorsStanford UniversityPhase 1 Recruiting18 enrolled
NCT03025256 2026-01-08Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal DiseaseM.D. Anderson Cancer CenterPhase 1 Active not recruiting71 enrolled